Dr. E. Anthone Ward

Public Hospitals Authority Bahamas
Director of Pharmaceutical Services at the Supplies


Dr. E. Anthone Ward firmly believes that ‘Of all forms of inequality, injustice in  healthcare is the most shocking and inhumane’ (Rev. Dr. Martin Luther King Jr. 1966).  To this end, he has pursued every opportunity to assist in the development of  programmes and initiatives that endeavour to ensure the highest quality of healthcare  services is delivered to the public.  

Dr. Ward has greater than two (2) decades of national and international experience in  areas relating to health systems development, healthcare services delivery and developing  strategies to overcome barriers/burdens to accessing healthcare services.  

Having conducted health research and matriculated in universities within the United  States of America, Canada and the United Kingdom, Dr. Ward attained extensive  knowledge, understanding and skills with regards to the diverse features and function of  the health system in these countries. Most notably, his enhanced knowledge of health  systems has enabled him to provide valuable insight pertinent to efficiencies and  inefficiencies – particularly the extension of services to underserved populations. During Dr. Ward’s early career at the Princess Margaret Hospital (PMH) in Nassau, Bahamas  saw him working with a US Consultancy Group as the Bahamian liaison on a Quality  Improvement Project and gained firsthand knowledge relating to many of the operational  deficiencies and areas of service requiring improvement.  

Dr. Ward received an In-service award from PMH to study as a full-time Ph.D.  Researcher at the University of Birmingham in the United Kingdom. As a PhD  researcher, he conducted an in-depth study on Equity in the Provision and Use of  Healthcare Services in The Bahamas. Dr. Ward’s study involved a critical analysis of the  health system in The Bahamas with an aim to assess the degree of equity in the provision  and use of public and private healthcare services (outpatient and inpatient) together with determining existing barriers and burdens to care. His thorough understanding of public  health services management and the operational issues associated with social insurance  health systems has enabled him to apply innovative methods in examining healthcare  delivery throughout The Bahamas.

During his fifteen (15) years of service as the Director of Shared Services at the Public  Hospitals Authority (PHA), Dr. Ward was able to develop Business Cases for the  restructuring of the Materials Management Directorate and Bahamas National Drug  Agency – coordinating the various tendering exercises of the PHA together with serving 

as the Deputy Chairman of the Drug Tender Selection Committee. In similar manner, he  also composed Requests-for-Proposals and Position Papers for PHA services and  products. As Director of Shared Services, he assisted in the development of various  Policy documents for the three (3) public hospitals and the public health system of The  Bahamas which provided him with extensive experience in the management of healthcare  services at the facility and systems level. 

Dr. Ward’s interpersonal skills and creativity have also been challenged and enhanced as  a key team player on various infrastructural projects within the three (3) public hospitals  in The Bahamas. As a member of the Executive Advisory Committee overseeing the  construction of the Critical Care Block (CCB) Project at the PMH in 2014, he worked  closely with internationally recruited design teams, medical equipment and health  planners during the phases of design, development and implementation of the CCB  Project.  

Since 2024, Dr. Ward has served as Director of Pharmaceutical Services at the Supplies  Management Agency of the PHA – coordinating the processes for tendering, selection and acquisition of pharmaceutical products throughout the public health care sector together with identifying and facilitating the development and implementation of system  improvement strategies for the efficient and effective delivery of pharmaceutical services.